Associated British Foods plc
Associated British Foods plc (ASBFY) Financial Performance & Income Statement Overview
Review Associated British Foods plc (ASBFY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Associated British Foods plc (ASBFY) Income Statement & Financial Overview
Explore comprehensive income reports for Associated British Foods plc ASBFY, broken down by year and quarter.
Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $9.51B | $10.34B | $9.73B | $10.19B |
Cost of Revenue | $8.74B | $9.38B | $8.85B | $9.46B |
Gross Profit | $765.00M | $960.00M | $880.00M | $733.00M |
Gross Profit Ratio | $0.08 | $0.09 | $0.09 | $0.07 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $25.50M |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $1.38B |
Operating Expenses | $55.00M | $0.00 | -$51.00M | $1.41B |
Total Costs & Expenses | $8.80B | $9.34B | $8.80B | $9.46B |
Interest Income | $0.00 | $36.00M | $35.00M | $26.00M |
Interest Expense | $0.00 | $73.00M | $62.00M | $69.00M |
Depreciation & Amortization | $336.00M | $505.00M | $305.00M | $461.00M |
EBITDA | $1.10B | $1.55B | $1.19B | $1.19B |
EBITDA Ratio | $0.12 | $0.15 | $0.12 | $0.12 |
Operating Income | $710.00M | $960.00M | $931.00M | $733.00M |
Operating Income Ratio | $0.07 | $0.09 | $0.10 | $0.07 |
Other Income/Expenses (Net) | -$18.00M | $8.00M | -$50.00M | -$385.00M |
Income Before Tax | $692.00M | $968.00M | $881.00M | $622.00M |
Income Before Tax Ratio | $0.07 | $0.09 | $0.09 | $0.06 |
Income Tax Expense | $163.00M | $234.00M | $203.00M | $170.00M |
Net Income | $520.00M | $792.00M | $663.00M | $517.00M |
Net Income Ratio | $0.05 | $0.08 | $0.07 | $0.05 |
EPS | $0.71 | $1.06 | $0.87 | $0.67 |
Diluted EPS | $0.71 | $1.06 | $0.87 | $0.67 |
Weighted Avg Shares Outstanding | $732.001M | $745.24M | $758.000M | $770.01M |
Weighted Avg Shares Outstanding (Diluted) | $732.00M | $745.24M | $758.00M | $770.01M |
Over the past four quarters, Associated British Foods plc demonstrated steady revenue growth, increasing from $10.19B in Q4 2023 to $9.51B in Q2 2025. Operating income reached $710.00M in Q2 2025, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.10B, reflecting operational efficiency. Net income dropped to $520.00M, with EPS at $0.71. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan